Moving Toward the Clinic- Leveraging Xenograft Models for Preclinical Anti-Cancer Studies

The use of cancer cell lines for in vitro studies of anti-cancer agents remains a primary component of preclinical drug development. These studies, however, struggle with significant pitfalls given the unique biology of cancer cell lines and the artificial assay...

/ November 2, 2017

Welcome to the nSolver™ Software Tech Blog!

We love that you’re here. Here’s why you’re going to love it, too: Fun-size articles on nSolver & Advanced Analysis. In between scientific papers, grant applications, and your other lengthy reading obligations, our blog post will be a fresh change...

/ October 25, 2017

Taking off the Blinders- The Acceleration of Integrated Multi-omic Analysis

Typically our fields require us to specialize; geneticists profile DNA and RNA, flow cytometrists look at extracellular protein markers, and system biologists look at complex data from six different instruments. We often stay in our single-omic lane, only deviating when absolute necessity...

/ October 18, 2017

Getting More from Flow Cytometry

Immunology studies rely on identifying unique cell populations, such as T cells and B cells, and then analyzing these cells to understand the biology of these cells. Studying different types of immune cells has provided insight into many fields, such...

/ October 2, 2017

Multi-Analyte Analysis of Lung Cancer FFPE Samples with 3D Biology™ Technology

NanoString sat down with McGarry Houghton, M.D., Associate Member of the Clinical Research and Human Biology Divisions at Fred Hutch Cancer Research Center, to discuss how his lab is using 3D Biology™ Technology to advance understanding of the lung tumor...

/ June 1, 2017